Search results
Earnings call: Lucid Group Q1 2024 earnings highlight growth and expansion By Investing.com
Investing.com· 5 days agoThe electric vehicle maker raised $1 billion in capital through a private placement of convertible...
Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry...
KAMR Amarillo· 5 days agoLucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary ...
Lucid reports Q1 net loss of $685 million and revenue of $173 million as cash burn continues
Automotive News· 6 days agoLucid CEO Peter Rawlinson was expected to update investors on this year's plans to launch the Gravity battery-electric crossover, the automaker's second vehicle, during < ...
Lucid Group Inc (LCID) Q1 2024 Earnings Call Transcript Highligh
Guru Focus· 7 days agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. Lucid Group Inc (LCID, Financial) reported better-than-expected production ...
Lucid Group, Inc. (NASDAQ:LCID) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoLucid Group, Inc. (NASDAQ:LCID) Q1 2024 Earnings Call Transcript May 6, 2024 Lucid Group, Inc....
Lucid stock down on Q1 loss, confirms Gravity SUV on track for 'late 2024' launch
AOL· 5 days agoEV maker Lucid (LCID) reported mixed first quarter results as a wider-than-expected loss trumped the company's confirmation that its Gravity SUV is still on track for a 2024 ...
Citizens (NASDAQ:CIZN) Stock Price Passes Below Two Hundred Day Moving Average of $8.39
ETF DAILY NEWS· 4 days agoCitizens Holding (NASDAQ:CIZN – Get Free Report)’s share price passed below its 200-day moving...
What's Going On With Lucid Stock Tuesday? - Lucid Gr (NASDAQ:LCID)
Benzinga· 5 days agoLucid Group Inc LCID shares are trading lower Tuesday on the heels of the company’s mixed...
Treace Medical Concepts (NASDAQ:TMCI) Price Target Lowered to $16.00 at UBS Group
ETF DAILY NEWS· 4 days agoTreace Medical Concepts (NASDAQ:TMCI – Free Report) had its target price decreased by UBS Group from $17.00 to $16.00 in a research report report published on Wednesday morning ...
KeyCorp Boosts MasTec (NYSE:MTZ) Price Target to $113.00
ETF DAILY NEWS· 4 days agoMasTec (NYSE:MTZ – Free Report) had its price objective raised by KeyCorp from $104.00 to $113.00 in a research report released on Monday morning, Benzinga reports. The brokerage ...